MARKET

CDMO

CDMO

Avid Bioservices
NASDAQ

Real-time Quotes | Nasdaq Last Sale

19.88
-1.34
-6.31%
Closed 16:14 05/05 EDT
OPEN
21.41
PREV CLOSE
21.22
HIGH
21.46
LOW
19.64
VOLUME
799.01K
TURNOVER
--
52 WEEK HIGH
22.14
52 WEEK LOW
5.08
MARKET CAP
1.21B
P/E (TTM)
-2285.0575
1D
5D
1M
3M
1Y
5Y
Agios' (AGIO) Q1 Earnings Miss, Pipeline Makes Progress
Zacks.com · 5d ago
Amarin (AMRN) Q1 Earnings Top, Vascepa Sales Hit by COVID-19
Zacks.com · 6d ago
Glaxo's (GSK) Q1 Earnings In Line, Sales Hit by COVID-19
Zacks.com · 6d ago
Strong New Drugs Sales to Aid AbbVie's (ABBV) Q1 Earnings
Zacks.com · 04/28 15:17
Avid Bioservices' (CDMO) Shares March Higher, Can It Continue?
Zacks · 04/27 15:31
Announcing: Avid Bioservices (NASDAQ:CDMO) Stock Soared An Exciting 755% In The Last Five Years
Simply Wall St. · 04/25 09:20
Is CDMO Stock A Buy or Sell?
A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshl...
Insider Monkey · 04/22 22:54
Allogene (ALLO) CAR T Therapy for Myeloma Gets FDA RMAT Tag
Zacks.com · 04/22 14:25
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CDMO. Analyze the recent business situations of Avid Bioservices through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CDMO stock price target is 22.00 with a high estimate of 24.00 and a low estimate of 21.00.
EPS
Institutional Holdings
Institutions: 192
Institutional Holdings: 42.92M
% Owned: 70.56%
Shares Outstanding: 60.83M
TypeInstitutionsShares
Increased
50
5.01M
New
45
5.18M
Decreased
29
4.62M
Sold Out
10
110.73K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.68%
Pharmaceuticals & Medical Research
+0.20%
Key Executives
Non-Executive Chairman/Independent Director
Joseph Carleone
President/Chief Executive Officer/Director
Nicholas Green
Chief Financial Officer
Daniel Hart
Chief Operating Officer
Richard Richieri
Vice President/General Counsel/Secretary
Mark Ziebell
Vice President
Magnus Schroeder
Other
Timothy Compton
Director
Richard Hancock
Other
Tim Compton
Independent Director
Mark Bamforth
Independent Director
Catherine Mackey
Independent Director
Gregory Sargen
Independent Director
Jeanne Thoma
Independent Director
Patrick Walsh
Declaration Date
Dividend Per Share
Ex-Div Date
03/07/2018
Dividend USD 0.6563
03/16/2018
  • All
  • Financials
  • Insiders
More
About CDMO
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

Webull offers kinds of Avid Bioservices Inc stock information, including NASDAQ:CDMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDMO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CDMO stock methods without spending real money on the virtual paper trading platform.